![Michael Wolfe](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Wolfe
Directeur des opérations chez Switch Therapeutics, Inc.
Profil
Michael Wolfe is currently the Senior Vice President-Finance & Operations at Switch Therapeutics, Inc. He previously worked as the Director-Finance & Business Operations at Kezar Life Sciences, Inc. and as the Head-Research & Development Finance at Onyx Pharmaceuticals, Inc. from 2010 to 2014.
He obtained his undergraduate degree from California Polytechnic State University (San Luis Obispo) in 2000.
Postes actifs de Michael Wolfe
Sociétés | Poste | Début |
---|---|---|
Switch Therapeutics, Inc.
![]() Switch Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Switch Therapeutics, Inc. is an American biotechnology company that aims to treat a range of diseases affecting the central nervous system and systemic indications with significant unmet need. Switch is based in , and was founded by Dee Datta, who has been the CEO since incorporation. The company is pioneering a new type of medicine that integrates nucleic acid nanotechnology and RNA interference (RNAi) science. The company's novel gene knockdown approach, the Conditionally Activated siRNA (CASI) platform, is based on technology developed by renowned researchers in the field of RNA and drug development from Caltech, Harvard Medical School, and City of Hope. | Directeur des opérations | 28/03/2023 |
Anciens postes connus de Michael Wolfe
Sociétés | Poste | Fin |
---|---|---|
KEZAR LIFE SCIENCES, INC. | Directeur des opérations | 01/01/2023 |
Onyx Pharmaceuticals, Inc.
![]() Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01/01/2014 |
Formation de Michael Wolfe
California Polytechnic State University (San Luis Obispo) | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
KEZAR LIFE SCIENCES, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Onyx Pharmaceuticals, Inc.
![]() Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Switch Therapeutics, Inc.
![]() Switch Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Switch Therapeutics, Inc. is an American biotechnology company that aims to treat a range of diseases affecting the central nervous system and systemic indications with significant unmet need. Switch is based in , and was founded by Dee Datta, who has been the CEO since incorporation. The company is pioneering a new type of medicine that integrates nucleic acid nanotechnology and RNA interference (RNAi) science. The company's novel gene knockdown approach, the Conditionally Activated siRNA (CASI) platform, is based on technology developed by renowned researchers in the field of RNA and drug development from Caltech, Harvard Medical School, and City of Hope. | Health Technology |